Search Results - "Romano Moreno, S."

Population pharmacokinetics of levetiracetam in neonates with seizures by Lima‐Rogel, V., López‐López, E. J., Medellín‐Garibay, S. E., Gómez‐Ruiz, L. M., Romero‐Méndez, C., Milán‐Segovia, R. C., Romano‐Moreno, S.

“…Summary What is known and objective This study developed a population pharmacokinetic (PK) model of levetiracetam (LEV) for treating neonatal seizures (NS) and…”
Get full text

Population pharmacokinetics of cefepime in neonates with severe nosocomial infections by Lima-Rogel, V., Medina-Rojas, E. L., Del Carmen Milán-Segovia, R., Noyola, D. E., Nieto-Aguirre, K., López-Delarosa, A., Romano-Moreno, S.

“…Summary Objective:  To define the pharmacokinetic behaviour of cefepime in neonates with severe nosocomial infections using a mixed effects model. Patients and…”
Get full text

Clinical Pharmacokinetics of Rifampin in Patients with Tuberculosis and Type 2 Diabetes Mellitus: Association with Biochemical and Immunological Parameters by Medellín-Garibay, S E, Cortez-Espinosa, N, Milán-Segovia, R C, Magaña-Aquino, M, Vargas-Morales, J M, González-Amaro, R, Portales-Pérez, D P, Romano-Moreno, S

“…Tuberculosis (TB) remains a major public health issue due to the increasing incidence of type 2 diabetes mellitus (T2DM), which exacerbates the clinical course…”
Get full text

Induction of transcription factors, miRNAs and cytokines involved in T lymphocyte differentiation in BCG-vaccinated subjects by Corral-Fernández, N.E., Cortez-Espinosa, N., Salgado-Bustamante, M., Romano-Moreno, S., Medellín-Garibay, S.E., Solis-Rodríguez, M., Hernández-Castro, B., Macías-Mendoza, J., González-Amaro, R., Portales-Pérez, D.P.

“…•Modulation of TBET and FOXP3 expression following the administration of the vaccine.•Both IL-10 and IFN-γ indicate a state of protection induced by the…”
Get full text

Population pharmacokinetics of rifampicin in Mexican patients with tuberculosis by Milán Segovia, R. C., Domínguez Ramírez, A. M., Jung Cook, H., Magaña Aquino, M., Vigna Pérez, M., Brundage, R. C., Romano Moreno, S.

“…Summary What is known and Objective:  Rifampicin (RIF) shows wide variability in its pharmacokinetics. The purpose of this study was to develop and validate a…”
Get full text

Expression of NAT2 in immune system cells and the relation of NAT2 gene polymorphisms in the anti-tuberculosis therapy in Mexican mestizo population by Salazar-González, R., Gómez, R., Romano-Moreno, S., Medellín-Garibay, S., Núñez-Ruíz, A., Magaña-Aquino, M., Milán-Segovia, R. C., Portales-Pérez, D. P.

“…Arylamine N-acetyltransferase 2 (NAT2) metabolizes isoniazid (INH) and Single Nucleotide Polymorphisms (SNP) responsible for its activity has been reported…”
Get full text

Relative bioavailability of rifampicin in a three-drug fixed-dose combination formulation by Milán-Segovia, Domínguez-Ramírez, Jung-Cook, Magaña-Aquino, Romero-Méndez, Medellín-Garibay, Vigna-Pérez, Romano-Moreno

“…SETTING: In a previous monitoring study of rifampicin (RMP) in tuberculosis (TB) patients treated with a generic formulation of a three-drug fixed-dose…”
Get full text

Relative bioavailability of isoniazid in a fixed-dose combination product in healthy Mexican subjects by Milán-Segovia, R. C., Vigna-Pérez, M., Romero-Méndez, M. C., Medellín-Garibay, S. E., Vargas-Morales, J. M., Magaña-Aquino, M., Romano-Moreno, S.

“…SETTING: Subtherapeutic plasma isoniazid (INH) concentrations and the development of bacterial resistance may be attributed to poor quality and reduced…”
Get full text

Quantitative analysis of regulatory T cells in kidney graft recipients: A relationship with calcineurin inhibitor level by Calvo-Turrubiartes, M, Romano-Moreno, S, García-Hernández, M, Chevaile-Ramos, J.A, Layseca-Espinosa, E, González-Amaro, R, Portales-Pérez, D

“…Abstract Background Monitoring of immunosuppressive drug levels can prevent some adverse effects in patients with solid organ transplantation. However, the…”
Get full text

Relationship among changes in hematocrit, albumin and corticosteroid dose on the disposition of tacrolimus during the first six months following renal transplantation by Robles-Piedras, A L, Romano-Moreno, S, Fuentes-Noriega, I, Mancilla-Urrea, E, González-López, E H, Domínguez-Ramírez, A

“…Tacrolimus is a macrolide immunosuppressant that is safe and effective for the prevention of rejection after kidney transplantation. The oral bioavailability…”
Get more information

Population pharmacokinetics of rifampicin in Mexican patients with tuberculosis: Population pharmacokinetics of rifampicin by Milán Segovia, R. C., Domínguez Ramírez, A. M., Jung Cook, H., Magaña Aquino, M., Vigna Pérez, M., Brundage, R. C., Romano Moreno, S.

Get full text